Clinical Trial Update: A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating tolerability and potential kidney-protective effects of empagliflozin in children and adolescents with chronic kidney disease,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Chronic Kidney Disease | Phase 3 | Status: RECRUITING